DUBLIN, Sept. 4, 2015 /PRNewswire/ -- Allergan plc
(NYSE: AGN) a leading global pharmaceutical company, today
announced that Brent Saunders, CEO
and President of Allergan, will provide an overview and update of
the Company's business at the Morgan Stanley Global Healthcare
Conference 2015 in New York,
NY.
Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO
The presentation will take place on Thursday, September 17, 2015 at 10:35 AM Eastern Time at the Grand Hyatt New
York, 109 East 42nd Street, New York,
NY 10017. To access a live webcast of the
presentation, visit Allergan's Investor Relations Web site at
http://ir.allergan.com. The webcast can also be accessed at
the following URL:
https://cc.talkpoint.com/morg007/091615a_ae/?entity=85_B74BL0P
An archived version will be available approximately one hour
after the live presentation ends and can be accessed at the same
locations for 90 days.
About Allergan
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global
pharmaceutical company and a leader in a new industry model –
Growth Pharma. Allergan is focused on developing,
manufacturing and commercializing innovative branded
pharmaceuticals, high-quality generic and over-the-counter
medicines and biologic products for patients around the
world.
Allergan markets a portfolio of best-in-class products that
provide valuable treatments for the central nervous system, eye
care, medical aesthetics, gastroenterology, women's health,
urology, cardiovascular and anti-infective therapeutic categories,
and operates the world's third-largest global generics business,
providing patients around the globe with increased access to
affordable, high-quality medicines. Allergan is an industry leader
in research and development, with one of the broadest development
pipelines in the pharmaceutical industry and a leading position in
the submission of generic product applications globally.
With commercial operations in approximately 100 countries,
Allergan is committed to working with physicians, healthcare
providers and patients to deliver innovative and meaningful
treatments that help people around the world live longer, healthier
lives.
For more information, visit Allergan's website at
www.allergan.com.
Forward-Looking Statement
Statements contained in this press release that refer to future
events or other non-historical facts are forward-looking statements
that reflect Allergan's current perspective of existing trends and
information as of the date of this release. Except as expressly
required by law, Allergan disclaims any intent or obligation to
update these forward-looking statements. Actual results may differ
materially from Allergan's current expectations depending upon a
number of factors affecting Allergan's business. These factors
include, among others, the risks associated with acquisition
transactions; the difficulty of predicting the timing or outcome of
FDA approvals or actions, if any; the impact of competitive
products and pricing; market acceptance of and continued demand for
Allergan's products; difficulties or delays in manufacturing; and
other risks and uncertainties detailed in Allergan's periodic
public filings with the Securities and Exchange Commission,
including but not limited to Allergan's Quarterly Report on Form
10-Q for the quarter ended June 30,
2015 (such periodic public filings having been filed under
the "Actavis plc" name) and from time to time in Allergan's other
investor communications . Except as expressly required by law,
Allergan disclaims any intent or obligation to update these
forward-looking statements.
CONTACTS:
|
|
|
Investors:
|
|
Lisa
DeFrancesco
|
|
(862)
261-7152
|
|
|
|
Media:
|
|
Mark
Marmur
|
|
(862)
261-7558
|
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/allergan-to-present-at-morgan-stanley-global-healthcare-conference-2015-300138043.html
SOURCE Allergan plc